{"entity":{"id":"nct06666166","kind":"trial","name":"SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer","aka":[],"tldr":"A phase 2 trial in colorectal cancer, run by Yunpeng Liu, not yet recruiting.","summary":"SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer is a phase 2, interventional study registered as NCT06666166 by Yunpeng Liu, with a registry enrolment figure of 28 participants, started 2024-12 and due to reach its primary completion in 2028-07. Interventions recorded: SHR-A1811 & Apartinib. Conditions listed: Advanced Gastric Carcinoma; Advanced Gastroesophageal Junction Adenocarcinoma; Advanced Colorectal Cancer. Primary outcome: Objective response rate (ORR). Colorectal eligibility wording from the registry: \"The function of major organs meets the following criteria(not transfused, not using haematopoietic factors and not corrected with drugs within 14 days):\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06666166","url":"https://clinicaltrials.gov/study/NCT06666166"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["hengrui"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06666166","phase":"2","setting":"Exploratory Clinical Study of SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer","sponsor":"Yunpeng Liu","enrolled":28,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06666166/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"company":[{"id":"hengrui","kind":"company","name":"Jiangsu Hengrui Pharmaceuticals","route":"/companies/hengrui/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}